Found: 10
Select item for more details and to access through your institution.
Switching from combination therapy with entecavir hydrate plus tenofovir alafenamide fumarate to tenofovir alafenamide fumarate monotherapy in patients with chronic hepatitis B based on nucleotide sequences of hepatitis B virus pregenome RNA.
- Published in:
- Hepatology Research, 2024, v. 54, n. 10, p. 877, doi. 10.1111/hepr.14036
- By:
- Publication type:
- Article
Hepatitis B surface antigen glycan isomer as a new potential biomarker in patients with hepatitis B virus infection.
- Published in:
- Hepatology Research, 2024, v. 54, n. 10, p. 874, doi. 10.1111/hepr.14106
- By:
- Publication type:
- Article
What we know and need to know about Fontan‐associated liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 10, p. 871, doi. 10.1111/hepr.14095
- By:
- Publication type:
- Article
Hepatitis B surface antigen (HBsAg) glycan isomer is predictive of HBsAg seroclearance in patients with chronic hepatitis B.
- Published in:
- Hepatology Research, 2024, v. 54, n. 10, p. 888, doi. 10.1111/hepr.14076
- By:
- Publication type:
- Article
Comparative analysis of sorafenib and lenvatinib on HepG2 cells and human umbilical vein endothelial cells: Involvement of transforming growth factor‐β signaling in their molecular effects.
- Published in:
- Hepatology Research, 2024, v. 54, n. 10, p. 921, doi. 10.1111/hepr.14045
- By:
- Publication type:
- Article
Epidemiological assessment of hepatitis E virus infection among 1565 pregnant women in Siem Reap, Cambodia using an in‐house double antigen sandwich ELISA.
- Published in:
- Hepatology Research, 2024, v. 54, n. 10, p. 899, doi. 10.1111/hepr.14041
- By:
- Publication type:
- Article
Epidemiology of Fontan‐associated liver disease in Japan: Results from a nationwide survey in 2021.
- Published in:
- Hepatology Research, 2024, v. 54, n. 10, p. 931, doi. 10.1111/hepr.14040
- By:
- Publication type:
- Article
Validation study of age‐independent fibrosis score (Fibrosis‐3 index) in patients with metabolic dysfunction‐associated steatotic liver disease.
- Published in:
- Hepatology Research, 2024, v. 54, n. 10, p. 912, doi. 10.1111/hepr.14039
- By:
- Publication type:
- Article
Role of PAR1 −506 deletion/insertion polymorphism in primary sclerosing cholangitis.
- Published in:
- Hepatology Research, 2024, v. 54, n. 10, p. 942, doi. 10.1111/hepr.14035
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Hepatology Research, 2024, v. 54, n. 10, p. 869, doi. 10.1111/hepr.13922
- Publication type:
- Article